CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways
Cystic fibrosis transmembrane conductance regulator (CFTR) is an ion transporter that regulates mucus hydration, viscosity and acidity of the airway epithelial surface. Genetic defects in CFTR impair regulation of mucus homeostasis, causing severe defects of mucociliary clearance as seen in cystic f...
Main Authors: | Sheylan D. Patel, Taylor R. Bono, Steven M. Rowe, George M. Solomon |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2020-06-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/29/156/190068.full |
Similar Items
-
Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
by: Buqing Yi, et al.
Published: (2021-03-01) -
Recent Progress in CFTR Interactome Mapping and Its Importance for Cystic Fibrosis
by: Sang Hyun Lim, et al.
Published: (2018-01-01) -
Candidate genes other than the CFTR gene as possible modifiers of pulmonary disease severity in cystic fibrosis
by: Frangolias, Despina Daisy
Published: (2008) -
Candidate genes other than the CFTR gene as possible modifiers of pulmonary disease severity in cystic fibrosis
by: Frangolias, Despina Daisy
Published: (2008) -
Candidate genes other than the CFTR gene as possible modifiers of pulmonary disease severity in cystic fibrosis
by: Frangolias, Despina Daisy
Published: (2008)